Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to understand the factors influencing the well-being and health of transgender and gender-diverse (TGD) individuals undergoing gender-affirming therapies in Swi...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Hospital, Basel, Switzerland
Collaborators
NCT06953908 · Gender Identity, Gender Dysphoria, Adult, and more
NCT05318755 · Transgender, Gender Incongruence
NCT04028219 · Gender Incongruence
NCT07128771 · Gender Incongruence, Cardiovascular Disease (CVD) Risk Factors
NCT05865262 · Transgender Individuals, QTc Interval
University Hospital of Basel
Basel
Cantonal Hospital of Lucerne
Lucerne
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions